Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Aggressive Behavior|February 18, 2020
Combining whole-school and targeted programs for the reduction of bullying victimization: A randomized, effectiveness trialRonald M Rapee, Therese Shaw, Caroline Hunt, et al.
The Lancet. Neurology|August 31, 2015
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detectionStefan Teipel, Alexander Drzezga, Michel J Grothe, et al.
Advances in Molecular Imaging|December 23, 2014
FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's DiseaseJohn Murray, Wai H Tsui, Yi Li, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian CancerNeetu Singh, Esther Need, Ayden Berndt, et al.
The International Journal of Behavioral Nutrition and Physical Activity|October 17, 2020
Development of physical activity policy and implementation strategies for early childhood education and care settings using the Delphi processHayley E Christian, Donna Cross, Michael Rosenberg, et al.
Science Advances|June 24, 2026
FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer DiseaseAnand K Deo, Soo Borson, Jeanne M Link, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Pageof 21